UMLS CUI | C0033578 |
UMLS Term | Prostatic Neoplasms |
MeSH ID | D011471 |
MeSH Term | Prostatic Neoplasms |
Disease Classes |
Neoplasms Male Urogenital Diseases |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
HDAC6 |
histone deacetylase 6 |
10013 |
Q9UBN7 |
chrX: 48,801,377-48,824,982 |
CDH13 |
cadherin 13 |
1012 |
P55290 |
chr16: 82,626,803-83,800,640 |
INADL |
InaD-like (Drosophila) |
10207 |
Q8NI35 |
chr1: 61,742,477-62,178,675 |
ABCC4 |
ATP binding cassette subfamily C member 4 |
10257 |
O15439 |
chr13: 95,019,829-95,301,446 |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
1026 |
P38936 |
chr6: 36,676,460-36,687,339 |
CDK2AP2 |
cyclin-dependent kinase 2 associated protein 2 |
10263 |
O75956 |
chr11: 67,506,497-67,508,649 |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
1027 |
P46527 |
chr12: 12,715,058-12,722,371 |
NDRG1 |
N-myc downstream regulated 1 |
10397 |
Q92597 |
chr8: 133,237,171-133,302,022 |
SPON2 |
spondin 2, extracellular matrix protein |
10417 |
Q9BUD6 |
chr4: 1,166,932-1,208,962 |
OLFM1 |
olfactomedin 1 |
10439 |
Q99784 |
chr9: 135,075,422-135,121,179 |
VAV3 |
vav guanine nucleotide exchange factor 3 |
10451 |
Q9UKW4 |
chr1: 107,571,160-107,965,144 |
NCOA2 |
nuclear receptor coactivator 2 |
10499 |
Q15596 |
chr8: 70,109,762-70,403,805 |
IVNS1ABP |
influenza virus NS1A binding protein |
10625 |
Q9Y6Y0 |
chr1: 185,296,388-185,317,329 |
RALBP1 |
ralA binding protein 1 |
10928 |
Q15311 |
chr18: 9,475,009-9,538,116 |
KDELR1 |
KDEL endoplasmic reticulum protein retention receptor 1 |
10945 |
P24390 |
chr19: 48,382,570-48,391,553 |
STARD3 |
StAR related lipid transfer domain containing 3 |
10948 |
Q14849 |
chr17: 39,637,065-39,663,484 |
CBX1 |
chromobox 1 |
10951 |
P83916 |
chr17: 48,070,052-48,101,521 |
SERINC3 |
serine incorporator 3 |
10955 |
Q13530 |
chr20: 44,496,221-44,522,109 |
ERP29 |
endoplasmic reticulum protein 29 |
10961 |
P30040 |
chr12: 112,013,316-112,023,451 |
LZTS1 |
leucine zipper, putative tumor suppressor 1 |
11178 |
Q9Y250 |
chr8: 20,246,165-20,303,963 |
PKP3 |
plakophilin 3 |
11187 |
Q9Y446 |
chr11: 392,614-404,908 |
TIRAP |
toll-interleukin 1 receptor (TIR) domain containing adaptor protein |
114609 |
P58753 |
chr11: 126,283,065-126,298,845 |
FOXP4 |
forkhead box P4 |
116113 |
Q8IVH2 |
chr6: 41,546,426-41,602,384 |
CLU |
clusterin |
1191 |
P10909 |
chr8: 27,596,917-27,615,031 |
SERPINA3 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
12 |
P01011 |
chr14: 94,612,377-94,624,055 |
TPP1 |
tripeptidyl peptidase I |
1200 |
O14773 |
chr11: 6,612,763-6,619,461 |
CNN3 |
calponin 3, acidic |
1266 |
Q15417 |
chr1: 94,896,949-94,927,278 |
COMT |
catechol-O-methyltransferase |
1312 |
P21964 |
chr22: 19,941,607-19,969,975 |
KLF6 |
Kruppel-like factor 6 |
1316 |
Q99612 |
chr10: 3,775,996-3,785,281 |
SLC31A1 |
solute carrier family 31 (copper transporter), member 1 |
1317 |
O15431 |
chr9: 113,221,562-113,264,492 |
CLDN3 |
claudin 3 |
1365 |
O15551 |
chr7: 73,768,997-73,770,270 |
CREBBP |
CREB binding protein |
1387 |
Q92793 |
chr16: 3,725,054-3,880,726 |
CRYAB |
crystallin alpha B |
1410 |
P02511 |
chr11: 111,908,565-111,923,722 |
PARP1 |
poly(ADP-ribose) polymerase 1 |
142 |
P09874 |
chr1: 226,360,691-226,408,079 |
SESN3 |
sestrin 3 |
143686 |
P58005 |
chr11: 95,165,513-95,232,541 |
CSRP1 |
cysteine and glycine rich protein 1 |
1465 |
P21291 |
chr1: 201,483,530-201,509,456 |
CTBP2 |
C-terminal binding protein 2 |
1488 |
P56545 |
chr10: 124,984,317-125,161,170 |
CTNNB1 |
catenin beta 1 |
1499 |
P35222 |
chr3: 41,194,837-41,260,096 |
CTSB |
cathepsin B |
1508 |
P07858 |
chr8: 11,842,524-11,869,448 |
CTSD |
cathepsin D |
1509 |
P07339 |
chr11: 1,752,752-1,764,573 |
ADRB2 |
adrenoceptor beta 2 |
154 |
P07550 |
chr5: 148,825,245-148,828,687 |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
1543 |
P04798 |
chr15: 74,719,542-74,725,610 |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
1545 |
Q16678 |
chr2: 38,066,973-38,109,902 |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
1548 |
P11509 |
chr19: 40,843,538-40,850,447 |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
1571 |
P05181 |
chr10: 133,520,406-133,561,220 |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
1576 |
P08684 |
chr7: 99,756,960-99,784,265 |
CYP3A5 |
cytochrome P450 family 3 subfamily A member 5 |
1577 |
P20815 |
chr7: 99,648,194-99,679,998 |
CYP17A1 |
cytochrome P450 family 17 subfamily A member 1 |
1586 |
P05093 |
chr10: 102,830,531-102,837,533 |
CYP19A1 |
cytochrome P450 family 19 subfamily A member 1 |
1588 |
P11511 |
chr15: 51,208,057-51,338,610 |
DAG1 |
dystroglycan 1 |
1605 |
Q14118 |
chr3: 49,468,703-49,535,618 |
ACE |
angiotensin I converting enzyme |
1636 |
P12821 |
chr17: 63,477,061-63,498,380 |
GADD45A |
growth arrest and DNA damage inducible alpha |
1647 |
P24522 |
chr1: 67,685,061-67,688,338 |
NQO1 |
NAD(P)H dehydrogenase, quinone 1 |
1728 |
P15559 |
chr16: 69,706,996-69,726,951 |
DNMT1 |
DNA (cytosine-5-)-methyltransferase 1 |
1786 |
P26358 |
chr19: 10,133,345-10,231,286 |
DNMT3B |
DNA (cytosine-5-)-methyltransferase 3 beta |
1789 |
Q9UBC3 |
chr20: 32,762,385-32,809,356 |
EGFR |
epidermal growth factor receptor |
1956 |
P00533 |
chr7: 55,019,021-55,211,628 |
EGR1 |
early growth response 1 |
1958 |
P18146 |
chr5: 138,465,490-138,469,315 |
AHR |
aryl hydrocarbon receptor |
196 |
P35869 |
chr7: 17,298,622-17,346,152 |
EMP1 |
epithelial membrane protein 1 |
2012 |
P54849 |
chr12: 13,196,716-13,219,939 |
EMP3 |
epithelial membrane protein 3 |
2014 |
P54852 |
chr19: 48,321,509-48,330,553 |
EPHX1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
2052 |
P07099 |
chr1: 225,810,092-225,845,563 |
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
2064 |
P04626 |
chr17: 39,687,914-39,730,426 |
ERBB3 |
erb-b2 receptor tyrosine kinase 3 |
2065 |
P21860 |
chr12: 56,079,857-56,103,505 |
ERCC2 |
excision repair cross-complementation group 2 |
2068 |
P18074 |
chr19: 45,349,837-45,370,918 |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
207 |
P31749 |
chr14: 104,769,349-104,795,751 |
ESR1 |
estrogen receptor 1 |
2099 |
P03372 |
chr6: 151,656,691-152,129,619 |
ALAD |
aminolevulinate dehydratase |
210 |
P13716 |
chr9: 113,386,317-113,401,333 |
ESR2 |
estrogen receptor 2 (ER beta) |
2100 |
Q92731 |
chr14: 64,084,232-64,338,112 |
ETV1 |
ets variant 1 |
2115 |
P50549 |
chr7: 13,891,228-13,991,425 |
EZH2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
2146 |
Q15910 |
chr7: 148,807,383-148,884,321 |
ACSL4 |
acyl-CoA synthetase long-chain family member 4 |
2182 |
O60488 |
chrX: 109,624,244-109,733,403 |
FBLN1 |
fibulin 1 |
2192 |
P23142 |
chr22: 45,502,238-45,601,135 |
JAZF1 |
JAZF zinc finger 1 |
221895 |
Q86VZ6 |
chr7: 27,830,573-28,180,743 |
FGF2 |
fibroblast growth factor 2 (basic) |
2247 |
P09038 |
chr4: 122,826,708-122,898,236 |
FHIT |
fragile histidine triad |
2272 |
P49789 |
chr3: 59,749,310-61,251,459 |
FOXC1 |
forkhead box C1 |
2296 |
Q12948 |
chr6: 1,609,972-1,613,897 |
ERP44 |
endoplasmic reticulum protein 44 |
23071 |
Q9BS26 |
chr9: 99,979,179-100,099,040 |
FAF2 |
Fas associated factor family member 2 |
23197 |
Q96CS3 |
chr5: 176,447,628-176,510,074 |
ARL6IP1 |
ADP ribosylation factor like GTPase 6 interacting protein 1 |
23204 |
Q15041 |
chr16: 18,791,667-18,801,678 |
BRD4 |
bromodomain containing 4 |
23476 |
O60885 |
chr19: 15,235,519-15,332,545 |
SSBP2 |
single-stranded DNA binding protein 2 |
23635 |
P81877 |
chr5: 81,413,021-81,751,797 |
TMEFF2 |
transmembrane protein with EGF-like and two follistatin-like domains 2 |
23671 |
Q9UIK5 |
chr2: 191,949,043-192,195,709 |
CIZ1 |
CDKN1A interacting zinc finger protein 1 |
25792 |
Q9ULV3 |
chr9: 128,166,064-128,204,383 |
PHGDH |
phosphoglycerate dehydrogenase |
26227 |
O43175 |
chr1: 119,648,411-119,744,226 |
EHF |
ets homologous factor |
26298 |
Q9NZC4 |
chr11: 34,621,093-34,661,057 |
PLEK2 |
pleckstrin 2 |
26499 |
Q9NYT0 |
chr14: 67,386,983-67,412,200 |
GHR |
growth hormone receptor |
2690 |
P10912 |
chr5: 42,423,777-42,721,878 |
GJA1 |
gap junction protein alpha 1 |
2697 |
P17302 |
chr6: 121,435,692-121,449,727 |
TNFRSF21 |
tumor necrosis factor receptor superfamily member 21 |
27242 |
O75509 |
chr6: 47,231,532-47,309,905 |
GNG5 |
guanine nucleotide binding protein (G protein), gamma 5 |
2787 |
P63218 |
chr1: 84,498,325-84,506,565 |
GOLGA4 |
golgin A4 |
2803 |
Q13439 |
chr3: 37,243,177-37,366,751 |
GPX3 |
glutathione peroxidase 3 |
2878 |
P22352 |
chr5: 151,020,438-151,028,993 |
KLF15 |
Kruppel-like factor 15 |
28999 |
Q9UIH9 |
chr3: 126,342,635-126,357,442 |
ABR |
active BCR-related |
29 |
Q12979 |
chr17: 1,003,518-1,229,021 |
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
2908 |
P04150 |
chr5: 143,277,931-143,435,512 |
THYN1 |
thymocyte nuclear protein 1 |
29087 |
Q9P016 |
chr11: 134,248,279-134,253,370 |
PDIA3 |
protein disulfide isomerase family A member 3 |
2923 |
P30101 |
chr15: 43,746,392-43,773,279 |
GSK3B |
glycogen synthase kinase 3 beta |
2932 |
P49841 |
chr3: 119,821,323-120,094,417 |
GSTA1 |
glutathione S-transferase alpha 1 |
2938 |
P08263 |
chr6: 52,791,664-52,803,910 |
GSTM1 |
glutathione S-transferase mu 1 |
2944 |
P09488 |
chr1: 109,687,814-109,709,039 |
GSTM3 |
glutathione S-transferase mu 3 (brain) |
2947 |
P21266 |
chr1: 109,733,932-109,741,038 |
GSTP1 |
glutathione S-transferase pi 1 |
2950 |
P09211 |
chr11: 67,583,595-67,586,660 |
GSTT1 |
glutathione S-transferase theta 1 |
2952 |
P30711 |
chr22: 24,033,952-24,042,493 |
PSMC3IP |
PSMC3 interacting protein |
29893 |
Q9P2W1 |
chr17: 42,572,315-42,577,831 |
EFEMP2 |
EGF containing fibulin-like extracellular matrix protein 2 |
30008 |
O95967 |
chr11: 65,866,441-65,873,592 |
ANXA1 |
annexin A1 |
301 |
P04083 |
chr9: 73,151,757-73,170,393 |
HBG1 |
hemoglobin subunit gamma 1 |
3047 |
P69891 |
chr11: 5,248,083-5,249,892 |
ANXA3 |
annexin A3 |
306 |
P12429 |
chr4: 78,551,519-78,610,451 |
ANXA4 |
annexin A4 |
307 |
P09525 |
chr2: 69,644,425-69,827,100 |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
3091 |
Q16665 |
chr14: 61,695,513-61,748,259 |
HIP1 |
huntingtin interacting protein 1 |
3092 |
O00291 |
chr7: 75,533,300-75,738,962 |
AOX1 |
aldehyde oxidase 1 |
316 |
Q06278 |
chr2: 200,585,868-200,677,064 |
HNRNPH1 |
heterogeneous nuclear ribonucleoprotein H1 (H) |
3187 |
P31943 |
chr5: 179,614,178-179,634,784 |
APC |
adenomatous polyposis coli |
324 |
P25054 |
chr5: 112,707,498-112,846,239 |
HPGD |
hydroxyprostaglandin dehydrogenase 15-(NAD) |
3248 |
P15428 |
chr4: 174,490,177-174,523,154 |
HSD3B1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
3283 |
P14060 |
chr1: 119,507,198-119,515,054 |
HSD3B2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
3284 |
P26439 |
chr1: 119,414,931-119,423,035 |
HSD17B1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
3292 |
P14061 |
chr17: 42,549,214-42,555,213 |
HSPA1A |
heat shock protein family A (Hsp70) member 1A |
3303 |
P0DMV8 |
chr6: 31,815,464-31,817,946 |
HSP90AB1 |
heat shock protein 90kDa alpha family class B member 1 |
3326 |
P08238 |
chr6: 44,246,166-44,253,888 |
ICAM1 |
intercellular adhesion molecule 1 |
3383 |
P05362 |
chr19: 10,270,835-10,286,615 |
ID3 |
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
3399 |
Q02535 |
chr1: 23,557,918-23,559,794 |
IGF1 |
insulin like growth factor 1 |
3479 |
P05019 |
chr12: 102,395,867-102,480,645 |
IGFBP3 |
insulin like growth factor binding protein 3 |
3486 |
P17936 |
chr7: 45,912,245-45,921,874 |
IGFBP6 |
insulin like growth factor binding protein 6 |
3489 |
P24592 |
chr12: 53,097,436-53,102,345 |
IGFBP7 |
insulin like growth factor binding protein 7 |
3490 |
Q16270 |
chr4: 57,030,773-57,110,385 |
KLK3 |
kallikrein related peptidase 3 |
354 |
P07288 |
chr19: 50,854,915-50,860,764 |
IL1RN |
interleukin 1 receptor antagonist |
3557 |
P18510 |
chr2: 113,107,214-113,134,016 |
IL6 |
interleukin 6 |
3569 |
P05231 |
chr7: 22,725,884-22,732,002 |
CXCL8 |
chemokine (C-X-C motif) ligand 8 |
3576 |
P10145 |
chr4: 73,740,506-73,743,716 |
IL10 |
interleukin 10 |
3586 |
P22301 |
chr1: 206,767,602-206,772,494 |
IL18 |
interleukin 18 |
3606 |
Q14116 |
chr11: 112,143,251-112,164,117 |
INS |
insulin |
3630 |
P01308 |
chr11: 2,159,779-2,161,341 |
IRS1 |
insulin receptor substrate 1 |
3667 |
P35568 |
chr2: 226,731,317-226,799,759 |
AR |
androgen receptor |
367 |
P10275 |
chrX: 67,544,032-67,730,619 |
ITGB3 |
integrin subunit beta 3 |
3690 |
P05106 |
chr17: 47,253,846-47,311,816 |
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
3708 |
Q14643 |
chr3: 4,493,348-4,847,840 |
JAK2 |
Janus kinase 2 |
3717 |
O60674 |
chr9: 4,984,390-5,128,183 |
JUP |
junction plakoglobin |
3728 |
P14923 |
chr17: 41,754,604-41,786,931 |
GSTK1 |
glutathione S-transferase kappa 1 |
373156 |
Q9Y2Q3 |
chr7: 143,244,093-143,270,854 |
KLK2 |
kallikrein related peptidase 2 |
3817 |
P20151 |
chr19: 50,861,568-50,880,567 |
LAMC1 |
laminin subunit gamma 1 |
3915 |
P11047 |
chr1: 183,023,460-183,145,592 |
STMN1 |
stathmin 1 |
3925 |
P16949 |
chr1: 25,884,181-25,906,991 |
LDHB |
lactate dehydrogenase B |
3945 |
P07195 |
chr12: 21,635,342-21,757,857 |
LEP |
leptin |
3952 |
P41159 |
chr7: 128,241,284-128,257,628 |
LIFR |
leukemia inhibitory factor receptor alpha |
3977 |
P42702 |
chr5: 38,474,963-38,608,354 |
LPL |
lipoprotein lipase |
4023 |
P06858 |
chr8: 19,901,717-19,967,258 |
LRP2 |
LDL receptor related protein 2 |
4036 |
P98164 |
chr2: 169,127,109-169,362,685 |
MIR21 |
microRNA 21 |
406991 |
N/A |
chr17: 59,841,266-59,841,337 |
EPCAM |
epithelial cell adhesion molecule |
4072 |
P16422 |
chr2: 47,345,158-47,387,601 |
MC2R |
melanocortin 2 receptor (adrenocorticotropic hormone) |
4158 |
Q01718 |
chr18: 13,882,044-13,915,707 |
MDM2 |
MDM2 proto-oncogene, E3 ubiquitin protein ligase |
4193 |
Q00987 |
chr12: 68,808,176-68,850,686 |
MIF |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
4282 |
P14174 |
chr22: 23,894,004-23,895,227 |
MLH1 |
mutL homolog 1 |
4292 |
P40692 |
chr3: 36,993,332-37,050,918 |
MME |
membrane metallo-endopeptidase |
4311 |
P08473 |
chr3: 155,024,124-155,183,729 |
MMP9 |
matrix metallopeptidase 9 |
4318 |
P14780 |
chr20: 46,008,908-46,016,561 |
MPO |
myeloperoxidase |
4353 |
P05164 |
chr17: 58,269,856-58,280,935 |
MSH3 |
mutS homolog 3 |
4437 |
P20585 |
chr5: 80,654,648-80,876,460 |
MT2A |
metallothionein 2A |
4502 |
P02795 |
chr16: 56,608,199-56,609,497 |
MTAP |
methylthioadenosine phosphorylase |
4507 |
Q13126 |
chr9: 21,802,543-21,937,651 |
MTHFR |
methylenetetrahydrofolate reductase (NAD(P)H) |
4524 |
P42898 |
chr1: 11,785,723-11,806,920 |
MUC4 |
mucin 4, cell surface associated |
4585 |
Q99102 |
chr3: 195,746,765-195,812,277 |
MXI1 |
MAX interactor 1, dimerization protein |
4601 |
P50539 |
chr10: 110,207,605-110,287,365 |
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
4609 |
P01106 |
chr8: 127,735,434-127,741,434 |
ZFHX3 |
zinc finger homeobox 3 |
463 |
Q15911 |
chr16: 72,782,885-73,144,447 |
NAGLU |
N-acetylglucosaminidase, alpha |
4669 |
P54802 |
chr17: 42,536,172-42,544,449 |
ATF3 |
activating transcription factor 3 |
467 |
P18847 |
chr1: 212,565,334-212,620,777 |
NBN |
nibrin |
4683 |
O60934 |
chr8: 89,933,336-90,003,228 |
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
4782 |
P08651 |
chr19: 3,314,403-3,469,217 |
NGFR |
nerve growth factor receptor |
4804 |
P08138 |
chr17: 49,495,293-49,515,017 |
NOS3 |
nitric oxide synthase 3 |
4846 |
P29474 |
chr7: 150,990,995-151,014,588 |
NPR3 |
natriuretic peptide receptor 3 |
4883 |
P17342 |
chr5: 32,689,070-32,791,724 |
NUCB2 |
nucleobindin 2 |
4925 |
P80303 |
chr11: 17,208,153-17,349,974 |
P4HB |
prolyl 4-hydroxylase, beta polypeptide |
5034 |
P07237 |
chr17: 81,843,159-81,860,694 |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
5054 |
P05121 |
chr7: 101,127,089-101,139,266 |
PAWR |
PRKC, apoptosis, WT1, regulator |
5074 |
Q96IZ0 |
chr12: 79,574,979-79,691,097 |
CRYL1 |
crystallin lambda 1 |
51084 |
Q9Y2S2 |
chr13: 20,403,667-20,525,857 |
RLIM |
ring finger protein, LIM domain interacting |
51132 |
Q9NVW2 |
chrX: 74,585,217-74,614,617 |
DCXR |
dicarbonyl/L-xylulose reductase |
51181 |
Q7Z4W1 |
chr17: 82,035,136-82,037,732 |
ZBTB7A |
zinc finger and BTB domain containing 7A |
51341 |
O95365 |
chr19: 4,044,364-4,066,945 |
PDE4D |
phosphodiesterase 4D |
5144 |
Q08499 |
chr5: 58,969,038-60,522,120 |
PDHA1 |
pyruvate dehydrogenase (lipoamide) alpha 1 |
5160 |
P08559 |
chrX: 19,343,893-19,361,705 |
RASD1 |
RAS, dexamethasone-induced 1 |
51655 |
Q9Y272 |
chr17: 17,494,437-17,496,395 |
SERPINF1 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
5176 |
P36955 |
chr17: 1,761,959-1,777,574 |
PENK |
proenkephalin |
5179 |
P01210 |
chr8: 56,436,674-56,446,734 |
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5290 |
P42336 |
chr3: 179,148,114-179,240,093 |
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
5293 |
O00329 |
chr1: 9,651,732-9,729,114 |
PLAU |
plasminogen activator, urokinase |
5328 |
P00749 |
chr10: 73,909,177-73,917,497 |
PLAUR |
plasminogen activator, urokinase receptor |
5329 |
Q03405 |
chr19: 43,646,095-43,670,547 |
RAB4B |
RAB4B, member RAS oncogene family |
53916 |
P61018 |
chr19: 40,778,216-40,796,938 |
DNAJC10 |
DnaJ heat shock protein family (Hsp40) member C10 |
54431 |
Q8IXB1 |
chr2: 182,716,041-182,794,464 |
PON1 |
paraoxonase 1 |
5444 |
P27169 |
chr7: 95,297,676-95,324,707 |
PPARA |
peroxisome proliferator-activated receptor alpha |
5465 |
Q07869 |
chr22: 46,150,521-46,243,756 |
APPL2 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
55198 |
Q8NEU8 |
chr12: 105,173,296-105,236,238 |
ATAD3A |
ATPase family, AAA domain containing 3A |
55210 |
Q9NVI7 |
chr1: 1,512,151-1,534,687 |
ADI1 |
acireductone dioxygenase 1 |
55256 |
Q9BV57 |
chr2: 3,497,361-3,519,736 |
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme |
5530 |
Q08209 |
chr4: 101,023,409-101,348,278 |
RFK |
riboflavin kinase |
55312 |
Q969G6 |
chr9: 76,385,517-76,394,517 |
RNF130 |
ring finger protein 130 |
55819 |
Q86XS8 |
chr5: 179,911,651-180,072,118 |
DCAF6 |
DDB1 and CUL4 associated factor 6 |
55827 |
Q58WW2 |
chr1: 167,935,783-168,075,843 |
VIMP |
VCP-interacting membrane selenoprotein |
55829 |
Q9BQE4 |
chr15: 101,270,817-101,277,500 |
PRKDC |
protein kinase, DNA-activated, catalytic polypeptide |
5591 |
P78527 |
chr8: 47,773,108-47,960,183 |
MAPK3 |
mitogen-activated protein kinase 3 |
5595 |
P27361 |
chr16: 30,114,105-30,123,506 |
DNAJC3 |
DnaJ heat shock protein family (Hsp40) member C3 |
5611 |
Q13217 |
chr13: 95,677,139-95,794,989 |
PRNP |
prion protein |
5621 |
P04156 |
chr20: 4,686,236-4,701,590 |
AZGP1 |
alpha-2-glycoprotein 1, zinc-binding |
563 |
P25311 |
chr7: 99,966,720-99,976,157 |
B2M |
beta-2-microglobulin |
567 |
P61769 |
chr15: 44,711,477-44,718,877 |
BAD |
BCL2 associated agonist of cell death |
572 |
Q92934 |
chr11: 64,269,830-64,284,704 |
PTEN |
phosphatase and tensin homolog |
5728 |
P60484 |
chr10: 87,863,113-87,971,930 |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
5743 |
P35354 |
chr1: 186,671,791-186,680,427 |
PTHLH |
parathyroid hormone-like hormone |
5744 |
P12272 |
chr12: 27,958,084-27,972,705 |
PTPRK |
protein tyrosine phosphatase, receptor type, K |
5796 |
Q15262 |
chr6: 127,968,779-128,520,674 |
BAX |
BCL2-associated X protein |
581 |
Q07812 |
chr19: 48,954,815-48,961,798 |
RAD23B |
RAD23 homolog B, nucleotide excision repair protein |
5887 |
P54727 |
chr9: 107,283,137-107,332,194 |
ENPP5 |
ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) |
59084 |
Q9UJA9 |
chr6: 46,159,187-46,170,971 |
BCL2 |
B-cell CLL/lymphoma 2 |
596 |
P10415 |
chr18: 63,123,346-63,320,128 |
RNASE4 |
ribonuclease, RNase A family, 4 |
6038 |
P34096 |
chr14: 20,684,100-20,701,215 |
RNASEL |
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) |
6041 |
Q05823 |
chr1: 182,573,634-182,589,256 |
ELAC2 |
elaC ribonuclease Z 2 |
60528 |
Q9BQ52 |
chr17: 12,992,391-13,018,187 |
RPL10 |
ribosomal protein L10 |
6134 |
P27635 |
chrX: 154,389,955-154,409,168 |
RPL12 |
ribosomal protein L12 |
6136 |
P30050 |
chr9: 127,447,674-127,451,405 |
RRAS |
related RAS viral (r-ras) oncogene homolog |
6237 |
P10301 |
chr19: 49,635,292-49,640,201 |
VPS52 |
VPS52 GARP complex subunit |
6293 |
Q8N1B4 |
chr6: 33,250,272-33,272,047 |
ACSM3 |
acyl-CoA synthetase medium-chain family member 3 |
6296 |
Q53FZ2 |
chr16: 20,610,243-20,797,581 |
BGLAP |
bone gamma-carboxyglutamate (gla) protein |
632 |
P02818 |
chr1: 156,241,962-156,243,321 |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
6387 |
P48061 |
chr10: 44,370,165-44,386,493 |
SEPP1 |
selenoprotein P, plasma, 1 |
6414 |
P49908 |
chr5: 42,799,880-42,887,392 |
SHBG |
sex hormone-binding globulin |
6462 |
P04278 |
chr17: 7,613,946-7,633,383 |
CYP3A43 |
cytochrome P450 family 3 subfamily A member 43 |
64816 |
Q9HB55 |
chr7: 99,828,013-99,866,102 |
SLC5A5 |
solute carrier family 5 (sodium/iodide cotransporter), member 5 |
6528 |
Q92911 |
chr19: 17,871,973-17,895,174 |
SLC12A2 |
solute carrier family 12 (sodium/potassium/chloride transporter), member 2 |
6558 |
P55011 |
chr5: 128,083,766-128,189,688 |
SLC22A3 |
solute carrier family 22 (organic cation transporter), member 3 |
6581 |
O75751 |
chr6: 160,348,268-160,452,581 |
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
664 |
Q12983 |
chr10: 131,966,455-131,982,013 |
SOD2 |
superoxide dismutase 2, mitochondrial |
6648 |
P04179 |
chr6: 159,669,057-159,762,529 |
SRD5A1 |
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
6715 |
P18405 |
chr5: 6,633,343-6,674,386 |
SRD5A2 |
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
6716 |
P31213 |
chr2: 31,522,480-31,581,067 |
BRCA1 |
breast cancer 1 |
672 |
P38398 |
chr17: 43,044,295-43,170,245 |
BRCA2 |
breast cancer 2 |
675 |
P51587 |
chr13: 32,315,474-32,400,266 |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
6774 |
P40763 |
chr17: 42,313,324-42,388,568 |
ZFP36L2 |
ZFP36 ring finger protein-like 2 |
678 |
P47974 |
chr2: 43,222,402-43,226,609 |
SULT1E1 |
sulfotransferase family 1E member 1 |
6783 |
P49888 |
chr4: 69,841,212-69,860,152 |
AURKA |
aurora kinase A |
6790 |
O14965 |
chr20: 56,369,389-56,392,337 |
SULT2A1 |
sulfotransferase family 2A member 1 |
6822 |
Q06520 |
chr19: 47,870,466-47,886,397 |
SURF4 |
surfeit 4 |
6836 |
O15260 |
chr9: 133,361,449-133,376,166 |
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7 |
6885 |
O43318 |
chr6: 90,513,573-90,587,045 |
TCP1 |
t-complex 1 |
6950 |
P17987 |
chr6: 159,778,498-159,789,749 |
PRDX2 |
peroxiredoxin 2 |
7001 |
P32119 |
chr19: 12,796,820-12,801,859 |
TGFA |
transforming growth factor alpha |
7039 |
P01135 |
chr2: 70,447,280-70,554,193 |
TGFB1 |
transforming growth factor beta 1 |
7040 |
P01137 |
chr19: 41,301,587-41,353,911 |
TGFBR2 |
transforming growth factor beta receptor II |
7048 |
P37173 |
chr3: 30,606,502-30,694,142 |
TLR4 |
toll-like receptor 4 |
7099 |
O00206 |
chr9: 117,704,332-117,716,871 |
TLR5 |
toll-like receptor 5 |
7100 |
O60602 |
chr1: 223,109,406-223,143,282 |
TMF1 |
TATA element modulatory factor 1 |
7110 |
P82094 |
chr3: 69,019,827-69,052,303 |
TMOD1 |
tropomodulin 1 |
7111 |
P28289 |
chr9: 97,501,180-97,601,748 |
TMSB4X |
thymosin beta 4, X-linked |
7114 |
P62328 |
chrX: 12,975,108-12,977,227 |
TOP2A |
topoisomerase (DNA) II alpha |
7153 |
P11388 |
chr17: 40,388,516-40,417,950 |
TP53 |
tumor protein p53 |
7157 |
P04637 |
chr17: 7,661,779-7,687,550 |
TPD52 |
tumor protein D52 |
7163 |
P55327 |
chr8: 80,034,745-80,231,232 |
TPD52L1 |
tumor protein D52-like 1 |
7164 |
Q16890 |
chr6: 125,119,049-125,264,407 |
TPT1 |
tumor protein, translationally-controlled 1 |
7178 |
P13693 |
chr13: 45,333,471-45,341,370 |
HSP90B1 |
heat shock protein 90kDa beta family member 1 |
7184 |
P14625 |
chr12: 103,930,107-103,953,645 |
TRAF1 |
TNF receptor associated factor 1 |
7185 |
Q13077 |
chr9: 120,902,393-120,929,173 |
TYMS |
thymidylate synthetase |
7298 |
P04818 |
chr18: 657,604-673,578 |
UCP3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
7352 |
P55916 |
chr11: 74,000,281-74,009,435 |
UCK2 |
uridine-cytidine kinase 2 |
7371 |
Q9BZX2 |
chr1: 165,827,531-165,911,618 |
UMPS |
uridine monophosphate synthetase |
7372 |
P11172 |
chr3: 124,730,366-124,749,273 |
VDR |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
7421 |
P11473 |
chr12: 47,841,537-47,943,048 |
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
EZR |
ezrin |
7430 |
P15311 |
chr6: 158,765,741-158,819,412 |
VIM |
vimentin |
7431 |
P08670 |
chr10: 17,228,259-17,237,593 |
ZBTB16 |
zinc finger and BTB domain containing 16 |
7704 |
Q05516 |
chr11: 114,059,593-114,250,676 |
ZFAND5 |
zinc finger, AN1-type domain 5 |
7763 |
O76080 |
chr9: 72,351,425-72,365,235 |
DDR1 |
discoidin domain receptor tyrosine kinase 1 |
780 |
Q08345 |
chr6: 30,876,421-30,900,156 |
STEAP4 |
STEAP4 metalloreductase |
79689 |
Q687X5 |
chr7: 88,270,892-88,306,891 |
GSTCD |
glutathione S-transferase, C-terminal domain containing |
79807 |
Q8NEC7 |
chr4: 105,708,778-105,847,728 |
ARHGEF5 |
Rho guanine nucleotide exchange factor 5 |
7984 |
Q12774 |
chr7: 144,355,288-144,380,632 |
CLPTM1L |
CLPTM1-like |
81037 |
Q96KA5 |
chr5: 1,317,744-1,345,099 |
CALR |
calreticulin |
811 |
P27797 |
chr19: 12,938,578-12,944,489 |
NCOA3 |
nuclear receptor coactivator 3 |
8202 |
Q9Y6Q9 |
chr20: 47,501,902-47,656,877 |
PCDH11Y |
protocadherin 11 Y-linked |
83259 |
Q9BZA8 |
chrY: 5,000,226-5,742,224 |
MAD1L1 |
MAD1 mitotic arrest deficient-like 1 (yeast) |
8379 |
Q9Y6D9 |
chr7: 1,815,793-2,233,243 |
UXT |
ubiquitously expressed prefoldin like chaperone |
8409 |
Q9UBK9 |
chrX: 47,651,798-47,659,161 |
CASP9 |
caspase 9 |
842 |
P55211 |
chr1: 15,490,832-15,526,534 |
CAV1 |
caveolin 1 |
857 |
Q03135 |
chr7: 116,524,785-116,561,184 |
CAV2 |
caveolin 2 |
858 |
P51636 |
chr7: 116,287,380-116,508,541 |
RUNX1 |
runt-related transcription factor 1 |
861 |
Q01196 |
chr21: 34,787,801-36,004,667 |
AKR1C3 |
aldo-keto reductase family 1, member C3 |
8644 |
P42330 |
chr10: 5,035,354-5,107,686 |
NCOA1 |
nuclear receptor coactivator 1 |
8648 |
Q15788 |
chr2: 24,491,914-24,770,702 |
EIF3A |
eukaryotic translation initiation factor 3 subunit A |
8661 |
Q14152 |
chr10: 119,033,670-119,080,823 |
B4GALT4 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 |
8702 |
O60513 |
chr3: 119,211,732-119,241,103 |
CBR1 |
carbonyl reductase 1 |
873 |
P16152 |
chr21: 36,069,941-36,073,166 |
TNFSF10 |
tumor necrosis factor superfamily member 10 |
8743 |
P50591 |
chr3: 172,505,508-172,523,507 |
ADAM9 |
ADAM metallopeptidase domain 9 |
8754 |
Q13443 |
chr8: 38,996,869-39,105,144 |
CREG1 |
cellular repressor of E1A-stimulated genes 1 |
8804 |
O75629 |
chr1: 167,529,677-167,553,767 |
NRP1 |
neuropilin 1 |
8829 |
O14786 |
chr10: 33,177,492-33,336,262 |
ALDH1A2 |
aldehyde dehydrogenase 1 family member A2 |
8854 |
O94788 |
chr15: 57,953,424-58,497,866 |
CCND2 |
cyclin D2 |
894 |
P30279 |
chr12: 4,273,772-4,305,350 |
ZNF160 |
zinc finger protein 160 |
90338 |
Q9HCG1 |
chr19: 53,066,606-53,103,436 |
ZBED1 |
zinc finger, BED-type containing 1 |
9189 |
O96006 |
chrX: 2,486,414-2,500,967 |
ZMYM3 |
zinc finger, MYM-type 3 |
9203 |
Q14202 |
chrX: 71,239,624-71,255,146 |
INTS4 |
integrator complex subunit 4 |
92105 |
Q96HW7 |
chr11: 77,878,720-77,994,678 |
CD9 |
CD9 molecule |
928 |
P21926 |
chr12: 6,199,715-6,238,271 |
FBXO44 |
F-box protein 44 |
93611 |
Q9H4M3 |
chr1: 11,654,375-11,663,327 |
GRHPR |
glyoxylate reductase/hydroxypyruvate reductase |
9380 |
Q9UBQ7 |
chr9: 37,422,666-37,436,990 |
GSTO1 |
glutathione S-transferase omega 1 |
9446 |
P78417 |
chr10: 104,235,356-104,267,459 |
GDF15 |
growth differentiation factor 15 |
9518 |
Q99988 |
chr19: 18,374,731-18,389,176 |
GREB1 |
growth regulation by estrogen in breast cancer 1 |
9687 |
Q4ZG55 |
chr2: 11,482,341-11,642,788 |
MED12 |
mediator complex subunit 12 |
9968 |
Q93074 |
chrX: 71,118,556-71,142,454 |